EDGAR Filing Documents for 0001104659-15-021088

Form 8-K - Current report:

SEC Accession No. 0001104659-15-021088

Filing Date

2015-03-19

Accepted

2015-03-19 17:01:48

Documents

Period of Report

2015-03-17

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	a15-6910_28k.htm	8-K	36803
2	EX-1.1	a15-6910_2ex1d1.htm	EX-1.1	267512
3	EX-5.1	a15-6910_2ex5d1.htm	EX-5.1	10508
4	EX-99.1	a15-6910_2ex99d1.htm	EX-99.1	11138
5	EX-99.2	a15-6910_2ex99d2.htm	EX-99.2	11433
	Complete submission text file	0001104659-15-021088.txt		338701

Mailing Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108

Business Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108 734-887-3903

Esperion Therapeutics, Inc. (Filer) CIK: 0001434868 (see all company filings)